For Immediate Release
Contact: Kim Coghill
kcoghill@dermpa.org
Mobile: 202-374-7535
April 25, 2024
SDPA Statement on Counterfeit Botox Reports
Alexandria, VA April 25, 2024 - The Society of Dermatology Physician Assistants (SDPA) is deeply concerned about recent reports of the use of counterfeit botulinum toxin injections leading to multiple cases of patient illness across the country. The improper administration of medical injectables or the use of counterfeit botulinum toxin, commonly referred to as “Botox,” can lead to serious health consequences. Botox treatments should only be sought by patients in a medical setting from licensed and trained medical professionals including dermatology physician assistants/associates (DermPAs™).
Botox is a safe and effective treatment for medical and cosmetic conditions. The use of counterfeit Botox or the administration of any injectables by untrained individuals brings a serious risk of adverse health conditions including vision impairment, infection, and severe muscle weakness leading to difficulty swallowing or breathing. It is vital for patients to remain vigilant and to only seek these treatments by a trained and licensed medical professional who can properly inform them of these and other possible risks.
DermPAs™ are highly trained medical professionals who provide excellent patient care in collaboration with a board-certified dermatologist. DermPAs™ are committed to patient safety through proper training and compliance with national and state regulations governing patient care.
###
About SDPA
The Society of Dermatology Physician Assistants (SDPA), founded in 1994, is a 501c6 non-profit professional organization composed of members who provide medical services with the collaboration of a board-certified dermatologist. With more than 4,700 members, the SDPA is committed to advancing the care of patients through the education and empowerment of DermPAs™. For more information, visit dermpa.org or follow the SDPA on Facebook, Twitter (@dermPA), Instagram (@derm_pa) and LinkedIn.
